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The British Journal of Sports Medicine published an opinion editorial advocating a 
revision of public health guidance on saturated fat [1]. Here we offer a rebuttal, 
incorporating evidence-based principles absent in the original editorial, focusing on 
the quality of the evidence presented and we discuss contradictory evidence in relation 
to saturated fat, low-density lipoprotein cholesterol (LDL-C), specific dietary 
interventions, and cardiovascular disease (CVD) alongside future directions. 
 
 
Effects of reducing saturated fat intake on cardiovascular disease 
 
The authors cite a 2015 ‘landmark’ meta-analysis of observational studies showing a 
lack of an association between saturated fat consumption and both all-cause mortality 
and cardiovascular outcomes [2]. According to best practice evidence-based methods, 
these types of studies provide low-quality evidence [3]. Indeed, the authors of the cited 
meta-analysis reported that the likelihood of the reported associations was ‘very 
low’[2], meaning we can have very little confidence in the findings. 
 
The authors have also overlooked a 2015 Cochrane meta-analysis of 17 randomised 
controlled trials (RCTs; ~59,000 participants) which showed moderate quality 
evidence that long-term reduction of dietary saturated fat lowered the risk of 
cardiovascular events (number needed to treat = 14) but had no statistical effect on 
all-cause mortality or cardiovascular outcomes [4]. In pre-planned subgroup analyses, 
cardiovascular events were reduced when saturated fat was replaced by 
polyunsaturated fat (but not by carbohydrates, protein, or monounsaturated fat) [4]. 
This is a caveat that has been observed and emphasised by others and is well 
acknowledged in the field [5]. 
 
To further support their view, the editorial authors turn to data from a 2004 post-hoc 
observational study (low quality evidence) of postmenopausal women with established 
coronary heart disease, which showed an inverse relation between self-reported 
saturated fat intake and progression of atherosclerosis [6]. Methodological 
weaknesses of this study include assessment of dietary intake only at baseline, with 
no information on changes in diet over the duration of follow-up and residual 
confounding. The authors of that observational study concluded: “this was a post hoc 
analysis among participants in a randomized trial, and our findings may not be 
generalizable to all postmenopausal women” [6]. 
 
Thus, the consensus viewpoint of a beneficial effect of reduced dietary saturated fat 
and replacement with polyunsaturated fat in the general population appears to be 
underpinned by a higher quality evidence base. 
 
 
Benefits of a Mediterranean diet on primary and secondary CVD 
 
The PREDIMED [7] and the Lyon Diet Heart [8] studies are cited by the authors as 
evidence of a protective effect from a ‘high-fat’ diet. However, the dietary interventions 
in both of these trials were designed to increase intake of unsaturated fats. The Lyon 
Heart study specifically aimed to reduce saturated fat intake, and in both studies the 
diets had a saturated fat content lower than UK recommendations. The PREDIMED 
study investigated the effects of a Mediterranean diet, including fish, whole grain 
cereals, and fruits and supplemented with extra-virgin olive oil versus the same 
Mediterranean diet supplemented with only mixed nuts, versus a control diet (which 
aimed for low fat intake) on primary prevention of CVD. Whereas the Lyon Diet Heart 
study compared a Mediterranean-style diet that was rich in alpha-linolenic acid-rich 
omega-3 polyunsaturated fat but low in total fat (30% dietary energy), saturated fat, 
cholesterol, and linolenic acid (omega-6 polyunsaturated fat), with a control group 
(standard French diet). The findings from both these studies support the current 
consensus to increase intakes of unsaturated dietary fats instead of saturated fat. 
These findings also suggest that placing a limit on the percentage of calories from 
unsaturated fats may be unwarranted, as has been acknowledged in a recent 
consensus [9]. 
 
 
LDL-C and cardiovascular mortality 
 
The authors claim that the cardiovascular risk of LDL-C has been exaggerated and 
support this contention with the 1973 data from the Minnesota Coronary Experiment 
(MCE) [10] and a systematic review of observational studies [11]. However, the 
authors have not addressed documented limitations of the MCE study, including 
discrepant event rates and selective outcome reporting, over 80% attrition (with lack 
of intention-to-treat analysis), and a small event rate difference (n=21), plausibly driven 
by a higher unexplained drop-out rate in the control group [12]. 
 
The cited systematic review reports a lack of an association between LDL-C and CVD 
and some evidence of an inverse association with all-cause mortality in elderly 
populations [10]. However, the methodological quality of this review has been rated 
poor, because of, among other limitations, a non-uniform application of 
inclusion/exclusion criteria, a lack of quality assessment of the included studies (low 
quality observational studies), failure to account for multifactorial analysis (i.e. lack of 
control for confounders), and not considering statin use (see Eatz letter in response to 
[10] and [13]). 
 
Moreover, any evidence-based discussion on LDL-C cannot omit large-scale RCT 
evidence showing that in people at high risk of cardiovascular disease or those who 
have established heart disease, LDL-C-reducing statin therapy reduces the risk of 
coronary deaths, myocardial infarction, strokes, and coronary revascularisation 
procedures by ~25% for each mmol/L reduction in LDL-C during each year it is taken, 
after the first [14]. 
 
Therefore, given the flaws of the referenced trial [9] and the systematic review of 
observational studies [11] and evidence in support of benefits of LDL-C therapy, it 
appears to be too early to dismiss LDL-C as a risk factor for cardiovascular disease 
and mortality. 
 
 
Time to move the discussion forward 
 
The authors choose a binary and simplistic approach that gives little regard to the 
complex narrative regarding saturated fats, as this is not a biologically homogeneous 
group of compounds. The triglyceride composition, fatty acid chain length, food 
source, and nutrients and non-nutritive compounds in the foods all determine the 
effects of saturated fat on health. This is a key point that is not considered in the 
editorial. We therefore encourage a move to food-based guidelines that takes these 
nuances into account. 
 
Similarly, it appears from the Lyon Heart Study and PREDIMED that the reduced risk 
of death associated with a diet higher in unsaturated and lower in saturated fat may 
not be simply via LDL-C dependent mechanisms. It is likely there are multiple 
pathways by which different dietary factors may modify risk alongside classical risk 
factors, including modulation of inflammatory pathways [15]. Insulin sensitivity [15], 
insulin concentrations [16], and altered lipid metabolism [17] are also probably 
important factors. 
 Biological pathways are not a zero-sum game, and over-simplified editorials that 
ignore their complexities do not serve science or the public. Good research and 
evidence-based practice demands that such discussions consider the totality of the 
evidence base and the inherent uncertainty in nutritional epidemiological studies and 
trials [18]. Journal editors play a pivotal role in ensuring that such balanced 
discussions take place. 
 
Finally, arbitrary concepts such as ‘real food’ are unlikely to offer a simple message 
for most people and their use risks manipulation according to personal, cultural, or 
societal values and morals and not scientific evidence. It is time to shift the narrative 
to a discussion of dietary patterns over and above individual macronutrients that 
considers collaborative efforts for improving the evidence base and our understanding 
of the complex relation between diet and health. 
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